Besides mesenchymal degeneration, cell proliferation, and necrosis, glioblastomas show a significantly increased vascular permeability and microvascular growth.[2] Apatinib is highly efficient in inhibiting angiogenesis, and the vascular endothelial growth factor signal is a representative critical treatment target. The gene discussed is VEGFA; the disease is glioblastoma.